Anna Embring

Anna Embring is affiliated with the Department of Oncology-Pathology at Karolinska Institutet, working within Åsa Carlsson Tedgren's research group. She holds a Medical degree (2002) and a Doctoral degree (2023) from Karolinska Institutet. Her research focuses on radiation oncology, particularly pediatric tumor reirradiation, proton therapy, and optimizing clinical radiotherapy protocols.

Key research areas include:

• Reirradiation safety and efficacy in CNS tumors
• Proton therapy dosimetry and side effect profiling
• National guideline development for pediatric radiotherapy
• Long-term outcomes of radiation therapy in children

Recent work highlights include:

• Systematic evaluation of proton vs photon radiotherapy toxicity
• Development of Swedish pediatric CNS tumor reirradiation guidelines
• Analysis of cumulative dose effects in head and neck cancers

Current grant-funded research includes the REMIT project (2024-2025) exploring reirradiation for diffuse midline glioma. She has contributed to over 30 peer-reviewed publications since 2017, emphasizing translational research between dosimetric innovation and clinical practice.